Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 3377557)

Published in Transplantation on June 15, 2012

Authors

Dany Anglicheau1, Thangamani Muthukumar, Aurélie Hummel, Ruchuang Ding, Vijay K Sharma, Darshana Dadhania, Surya V Seshan, Joseph E Schwartz, Manikkam Suthanthiran

Author Affiliations

1: Department of Kidney Transplantation, Necker Hospital, Assistance Publique Hôpitaux de Paris-APHP, Université Paris Descartes Sorbonne Paris Cité, Paris, France.

Articles cited by this

Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 14.01

The myofibroblast: one function, multiple origins. Am J Pathol (2007) 8.64

Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09

Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02

Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol (2010) 3.75

Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med (2001) 3.16

Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res (2007) 2.80

Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55

Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest (2011) 2.43

Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest (2010) 2.42

MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36

Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol (2002) 2.31

Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol (2010) 2.09

Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol (2010) 1.93

Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50

A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol (2004) 1.48

Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol (2002) 1.44

Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol (2008) 1.29

Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int (2001) 1.25

Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int (1999) 1.25

Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation (2007) 1.21

Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int (2000) 1.19

Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int (2007) 1.17

Animal models of renal fibrosis. Methods Mol Med (2005) 1.11

Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol (1997) 1.11

Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int (2000) 1.06

Safety of kidney biopsy in pediatric transplantation: a report of the Controlled Clinical Trials in Pediatric Transplantation Trial of Induction Therapy Study Group. Transplantation (1999) 1.05

A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int (2000) 1.02

Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. Nephrol Dial Transplant (2009) 1.00

Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens (2002) 1.00

HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease. Front Biosci (2008) 0.99

Differential expression of profibrotic and growth factors in chronic allograft nephropathy. Transplantation (2006) 0.99

Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int (1996) 0.98

Percutaneous needle biopsy of the transplanted kidney: technique and complications. Am J Kidney Dis (1989) 0.96

Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant. Transplantation (2007) 0.96

Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med (2008) 0.94

Analysis of factors associated with complications following renal transplant needle core biopsy. Br J Urol (1994) 0.93

Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection. Transplantation (1995) 0.90

Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection. Kidney Int (1995) 0.89

Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction. Clin Transplant (2009) 0.88

Evaluating the accuracy of functional biomarkers for detecting histological changes in chronic allograft nephropathy. Transpl Int (2007) 0.87

Symposium: evaluating the reproducibility of pathological diagnosis using the 1997 Banff classification update. Clin Transplant (2006) 0.86

Relationship between vimentin expressing renal tubules and interstitial fibrosis in chronic progressive nephropathy in aged rats. Virchows Arch (1998) 0.83

Chronic renal allograft damage: existing challenges. Transplantation (2011) 0.83

Increased levels of serum hepatocyte growth factor in patients with end-stage renal disease. J Med (2000) 0.78

Articles by these authors

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 7.86

Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation (2003) 7.68

HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res (2004) 5.40

Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02

Patient compliance with paper and electronic diaries. Control Clin Trials (2003) 4.80

The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77

Patient non-compliance with paper diaries. BMJ (2002) 4.50

A snapshot of the age distribution of psychological well-being in the United States. Proc Natl Acad Sci U S A (2010) 3.67

Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65

Pathologic classification of diabetic nephropathy. J Am Soc Nephrol (2010) 3.61

Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

Ectopic expression of BABY BOOM triggers a conversion from vegetative to embryonic growth. Plant Cell (2002) 2.95

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med (2007) 2.86

Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation (2002) 2.86

Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med (2006) 2.68

Short- and long-term incidence of stroke in white-coat hypertension. Hypertension (2004) 2.58

Masked hypertension. Hypertension (2002) 2.57

The accuracy of pain and fatigue items across different reporting periods. Pain (2008) 2.57

Socioeconomic status, race, and diurnal cortisol decline in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosom Med (2006) 2.52

CLV3 is localized to the extracellular space, where it activates the Arabidopsis CLAVATA stem cell signaling pathway. Plant Cell (2002) 2.52

Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant. Kidney Int (2009) 2.40

Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int (2004) 2.39

Intensive momentary reporting of pain with an electronic diary: reactivity, compliance, and patient satisfaction. Pain (2003) 2.36

MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36

Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum (2009) 2.33

Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens (2008) 2.31

Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic. Pers Soc Psychol Bull (2005) 2.26

Large ventral lateral neurons modulate arousal and sleep in Drosophila. Curr Biol (2008) 2.26

Losing life and livelihood: a systematic review and meta-analysis of unemployment and all-cause mortality. Soc Sci Med (2011) 2.23

Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol (2011) 2.20

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects. Nephrol Dial Transplant (2007) 2.17

Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psychiatry (2010) 2.15

Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med (2010) 2.12

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2007) 2.10

The impact of perceived hypertension status on anxiety and the white coat effect. Ann Behav Med (2007) 2.08

Would you perform thrombolysis in this acute ischemic stroke patient? Arch Neurol (2009) 2.03

Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. Am J Hypertens (2012) 2.01

Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med (2008) 2.00

Circadian- and light-dependent regulation of resting membrane potential and spontaneous action potential firing of Drosophila circadian pacemaker neurons. J Neurophysiol (2007) 1.94

Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med (2011) 1.93

Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes. Am J Hypertens (2008) 1.91

Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. Clin J Am Soc Nephrol (2012) 1.89

Consistency of blood pressure differences between the left and right arms. Arch Intern Med (2007) 1.89

Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int (2003) 1.83

The E3 ubiquitin ligase BIG BROTHER controls arabidopsis organ size in a dosage-dependent manner. Curr Biol (2006) 1.77

Socioeconomic and psychosocial factors mediate race differences in nocturnal blood pressure dipping. Am J Hypertens (2009) 1.75

Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India. Am J Trop Med Hyg (2005) 1.73

Kidney tubular toxicity of maintenance pemetrexed therapy. Am J Kidney Dis (2011) 1.72

Acute renal infarction: a case series. Clin J Am Soc Nephrol (2012) 1.68

Understanding recall of weekly pain from a momentary assessment perspective: absolute agreement, between- and within-person consistency, and judged change in weekly pain. Pain (2004) 1.67

Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain (2004) 1.66

Personality and mortality risk across the life span: the importance of conscientiousness as a biopsychosocial attribute. Health Psychol (2007) 1.62

A population approach to the study of emotion: diurnal rhythms of a working day examined with the Day Reconstruction Method. Emotion (2006) 1.62

Deceased-donor kidney transplantation: improvement in long-term survival. Nephrol Dial Transplant (2010) 1.60

Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation (2014) 1.60

Multiplex fluorogenic real-time PCR for detection and quantification of Escherichia coli O157:H7 in dairy wastewater wetlands. Appl Environ Microbiol (2002) 1.60

Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people. Cochrane Database Syst Rev (2012) 1.59

Sustained blood pressure increase after an acute stressor: the effects of the 11 September 2001 attack on the New York City World Trade Center. J Hypertens (2005) 1.58

Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int (2005) 1.57

Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension (2009) 1.57

Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens (2009) 1.57

Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension (2006) 1.56

Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis. Hypertension (2008) 1.54

Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring. J Rheumatol (2005) 1.53

Arterial stiffness in chronic inflammatory diseases. Hypertension (2005) 1.53

Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey. Soc Psychiatry Psychiatr Epidemiol (2005) 1.51

Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. J Consult Clin Psychol (2003) 1.50

Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50

Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48